Switzerland· 66779001
Symtuza, Filmtabletten
A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing darunavirum, cobicistatum, emtricitabinum, tenofovirum alafenamidum, registered in Switzerland by Janssen-Cilag AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- darunavirum, cobicistatum, emtricitabinum, tenofovirum alafenamidum
- Manufacturer
- Janssen-Cilag AG
- Country
- Switzerland (CH)
- ATC code
- J05AR22
- ATC class
- Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768066779001330 StkCHF 1013.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
- CanadaSYMTUZAJANSSEN INC
- United KingdomSymtuza 800mg/150mg/200mg/10mg tabletsJanssen-Cilag Ltd
- PolandSymtuzaJanssen-Cilag International N.V.
- United StatesSymtuzaJanssen Products LP
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Symtuza
- Liechtenstein · Symtuza
- Norway · Symtuza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c6d79b4-e08b-43a7-8679-80101f89fcff GET /v1/drugs/8c6d79b4-e08b-43a7-8679-80101f89fcff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "darunavirum 800 mg + cobicistatum 150 mg + emtricitabinum 200 mg + tenofovirum alafenamidum 10 mg",
"valid_from": "2019-07-01",
"limitations": null,
"galenic_form": "Filmtabl",
"therapeutic_area": null,
"sl_inclusion_date": "2019-07-01",
"self_retention_pct": 10
}See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.